MUMBAI, India, May 30 -- Intellectual Property India has published a patent application (202517044188 A) filed by Chiesi Farmaceutici S. P. A., Parma, Italy, on May 7, for 'modified release pharmaceutical formulations comprising deferiprone.'
Inventor(s) include Gazzaniga Andrea; Cerea Matteo; Foppoli Anastasia; and Pertile Marisa.
The application for the patent was published on May 30, under issue no. 22/2025.
According to the abstract released by the Intellectual Property India: "The invention is directed to pharmaceutical compositions for oral administration comprising deferiprone. In particular the invention is directed to a modified release formulation in form of mini tablets suitable for twice a day oral administration for the treatment of diseases which cause an overload of iron for example thalassemia sickle cell anemia hemochromatosis and myelodysplasia or for the prevention and/or treatment of diseases which are caused by an overload of iron. The invention is also directed to methods of making said formulation."
The patent application was internationally filed on Oct. 13, 2023, under International application No.PCT/EP2023/078445.
Disclaimer: Curated by HT Syndication.
